Health Catalyst, Inc. reported fourth‑quarter 2025 results on March 12, 2026, with revenue of $74.7 million and adjusted EBITDA of $13.8 million. The company also posted an adjusted earnings per share of $0.08, missing the consensus estimate of $0.10. The revenue beat was driven by a modest 0.5% increase in technology revenue to $51.9 million, while professional services revenue fell 18.6% to $22.8 million, reflecting a shift toward higher‑margin offerings.
The earnings miss can be attributed to higher operating costs and a GAAP net loss of $178 million, largely driven by impairment charges. The company’s focus on restructuring and platform migration has increased short‑term expenses, offsetting the gains from improved gross margins.
For the full year, Health Catalyst generated $311.1 million in revenue, a 1% increase from $307 million in 2024, and achieved adjusted EBITDA of $41.4 million, a 59% rise from $26 million. Adjusted gross margin expanded to 51.1% from 39% year‑over‑year, driven by the higher mix of technology revenue and cost‑control initiatives.
Management provided guidance for the first quarter of 2026, projecting revenue of $68–$70 million, below the consensus estimate of $74.9 million. The company declined to issue full‑year 2026 guidance, citing an ongoing strategic and operational review linked to the CEO transition.
Investors reacted negatively to the guidance, citing concerns about the company’s near‑term revenue outlook and the challenges associated with the Ignite platform migration. The guidance cut signals uncertainty about the company’s ability to sustain revenue growth amid the migration and potential churn.
Management emphasized that the company’s restructuring efforts are yielding positive results, noting that adjusted EBITDA growth reflects improved profitability. They also highlighted a focus on long‑term success and the exploration of all options to drive shareholder value, including a potential sale if necessary.
Headwinds include the ongoing migration to the Ignite platform, which has impacted revenue in 2026 and 2027, and a $12.5 million decline in DaaS‑related ARR. Tailwinds are the expansion of platform clients, improved adjusted profitability, and a higher‑margin technology mix.
The results underscore a mixed outlook: while profitability metrics have improved, the company faces revenue headwinds and a cautious guidance stance, indicating that management remains uncertain about the pace of growth during the transition period.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.